Overview Financials News + Filings Key Docs Charts Ownership
|
Intellipharmaceutics International Inc. (IPCI)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions of CAD, except per share items | Nov-30-21 | Nov-30-20 | Nov-30-19 | Nov-30-18 | Nov-30-17 | Nov-30-16 | Nov-30-15 | Nov-30-14 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | 11.7 | -34.8 | 0.1 | 0.7 | 12.2 | | | |
Asset turnover | 0.0 | 0.4 | 0.5 | 0.2 | 0.7 | 0.3 | 0.6 | 1.4 |
|
Returns on Capital |
ROIC (excluding intangibles) | | | | -686.5% | -460.7% | -1575.4% | -638.7% | -218.3% |
ROIC (including intangibles) | 1.6% | 208.5% | 779.8% | -809.9% | -369.5% | -729.1% | 7072.9% | -151.7% |
ROE | 1.2% | 150.2% | 288.1% | -324.8% | -2139.3% | -882.5% | 5166.4% | -72.0% |
ROA | -4.9% | -280.1% | -412.6% | -116.1% | -111.7% | -123.5% | -136.2% | -44.9% |
|
Cash Conversion Cycle |
Days sales outstanding | | 147.5 | 18.6 | 50.9 | 45.7 | 76.7 | 42.7 | 42.1 |
Days payables outstanding | 2,101.7 | -186.4 | 41,469.4 | 7,726.9 | 1,068.1 | | | |
Days inventory outstanding | | -5.1 | 3,853.7 | 735.6 | 60.0 | | | |
Cash conversion cycle | | 328.7 | -37,597.2 | -6,940.3 | -962.4 | | | |
|